Alto Neuroscience Inc. (NYSE: ANRO) last traded at $34.28, up 0.09% on the session. The quote above updates while this page is open; the figures below are drawn from Alto Neuroscience Inc.’s own filings and are restated only when a new one is published.
Alto Neuroscience Inc. trades on NYSE under the ticker ANRO. Its market capitalisation is $1.35 billion.
Valuation measures for Alto Neuroscience Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $1.35B |
|---|---|
| Enterprise value | $1.14B |
| Price / book | 6.14 |
| Beta | 2.28 |
Trailing-twelve-month figures tagged in Alto Neuroscience Inc.'s XBRL filings with the SEC.
| Net income (TTM) | -$84.24M |
|---|---|
| EPS (TTM) | -$2.43 |
| Return on equity | -38.42% |
| Cash | $243.73M |
Range and volume for ANRO over the past 52 weeks.
| 52-week high | $35.41 |
|---|---|
| 52-week low | $3.41 |
| Volume | 238.7K |
| Average volume | 521.1K |
| Previous close | $34.25 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.